Webinar is over. Atomo is well-positioned to commercialise multiple verticals including COVID over the longer term.
- Capacity is now 1.6M Units. After commissioning additional machines they expect 2.5M per month capacity by next year which will be 30M annualised.
- DIVOC and Indian market entry still alive, pending FDA Approval by June 30th. This approval is beyond and EUA and will position Atomo as a premium offering.
- Additional European partner in advance stages
- HIV tenders were paused from the Global Fund last year, now back online and Atomo expect demand from this moving forward.
- 2-3 new OEM opportunities coming online over the medium term plus new device platforms including Telehealth consumer app being pursued.
The sell off is an opportunity and with COVID being a 3-5 year demand driver for the business I still see it as a buy with manufacturing scale up risk out of the way.
- Forums
- ASX - By Stock
- AT1
- AT1 FY21 - General Discussion + FA
AT1 FY21 - General Discussion + FA, page-853
-
- There are more pages in this discussion • 1,581 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
|
|||||
Last
2.2¢ |
Change
-0.002(8.33%) |
Mkt cap ! $14.06M |
Open | High | Low | Value | Volume |
2.1¢ | 2.3¢ | 2.1¢ | $1.75K | 77.75K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28439 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 281206 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28439 | 0.022 |
2 | 176861 | 0.021 |
7 | 957000 | 0.020 |
6 | 790840 | 0.019 |
3 | 185553 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 281206 | 5 |
0.025 | 339000 | 3 |
0.026 | 390045 | 2 |
0.027 | 1093000 | 3 |
0.028 | 550000 | 2 |
Last trade - 15.46pm 16/08/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |